Talmadge King, MD

Dean of the School of Medicine and Vice Chancellor for Medical Affairs
Pulmonologist

Dr. Talmadge E. King, Jr. is dean of the School of Medicine and vice chancellor for medical affairs at UCSF. His focus in patient care is interstitial lung diseases, in particular idiopathic pulmonary fibrosis, sarcoidosis, connective tissue disease, hypersensitivity pneumonitis, drug-induced lung fibrosis and other rare diffuse lung disorders. King's research interests include pathogenesis, diagnosis and management of inflammatory and immunologic lung disease. He has co-authored eight books, including the acclaimed reference book, "Interstitial Lung Disease," now in its fifth edition.

King earned a medical degree at Harvard Medical School, followed by a residency at Emory University Affiliated Hospitals in Atlanta, Ga., and a pulmonary fellowship at the University of Colorado Health Sciences Center in Denver. He is a member of the Association of American Physicians, American Clinical and Climatological Association and Fleischner Society and is a fellow of the American College of Physicians and the American College of Chest Physicians. He holds the Julius R. Krevans Distinguished Professorship in Internal Medicine and won the 2007 Trudeau Medal, the highest honor of the American Lung Association and American Thoracic Society.

Clinics

ILD Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-2577
Fax: (415) 353-8944

Conditions & Treatments

Board Certification

Pulmonary Disease, American Board of Internal Medicine

More about Talmadge King

Education

Harvard School of Medicine 1974

Residencies

Emory University Affiliated Hospitals, Internal Medicine 1977

Fellowships

University of Colorado Medical Center, Pulmonary/Critical Care 1979

Selected Research and Publications

  1. Lucey CR, Navarro R, King TE. Lessons From an Educational Never Event. JAMA Intern Med. 2017 Oct 01; 177(10):1415-1416.
  2. Morisset J, Vittinghoff E, Elicker BM, Hu X, Le S, Ryu JH, Jones KD, Haemel A, Golden JA, Boin F, Ley B, Wolters PJ, King TE, Collard HR, Lee JS. Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL Model. Chest. 2017 11; 152(5):999-1007.
  3. Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE, Kim DS, Collard HR, Lee JS. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease. Respir Med. 2017 Jun; 127:51-56.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.